These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 3346671

  • 1. [3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain.
    Scherman D, Raisman R, Ploska A, Agid Y.
    J Neurochem; 1988 Apr; 50(4):1131-6. PubMed ID: 3346671
    [Abstract] [Full Text] [Related]

  • 2. Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions.
    Scherman D.
    J Neurochem; 1986 Aug; 47(2):331-9. PubMed ID: 3734781
    [Abstract] [Full Text] [Related]

  • 3. Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin.
    Darchen F, Masuo Y, Vial M, Rostene W, Scherman D.
    Neuroscience; 1989 Aug; 33(2):341-9. PubMed ID: 2622531
    [Abstract] [Full Text] [Related]

  • 4. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L, Crooks PA, Dwoskin LP.
    J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
    [Abstract] [Full Text] [Related]

  • 5. The regionalization of [3H]dihydrotetrabenazine binding sites in the mouse brain and its relationship to the distribution of monoamines and their metabolites.
    Scherman D, Boschi G, Rips R, Henry JP.
    Brain Res; 1986 Apr 02; 370(1):176-81. PubMed ID: 2423178
    [Abstract] [Full Text] [Related]

  • 6. Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
    Lehéricy S, Brandel JP, Hirsch EC, Anglade P, Villares J, Scherman D, Duyckaerts C, Javoy-Agid F, Agid Y.
    Brain Res; 1994 Oct 03; 659(1-2):1-9. PubMed ID: 7820649
    [Abstract] [Full Text] [Related]

  • 7. Postnatal development of the monoamine vesicular transporter in mesencephalic and telencephalic regions of the rat brain: a quantitative autoradiographic study with [3H]dihydrotetrabenazine.
    Leroux-Nicollet I, Darchen F, Scherman D, Costentin J.
    Neurosci Lett; 1990 Sep 04; 117(1-2):1-7. PubMed ID: 2290604
    [Abstract] [Full Text] [Related]

  • 8. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
    Zucker M, Weizman A, Rehavi M.
    Life Sci; 2001 Sep 28; 69(19):2311-7. PubMed ID: 11669473
    [Abstract] [Full Text] [Related]

  • 9. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PA.
    J Pharmacol Exp Ther; 1988 Jan 28; 244(1):310-21. PubMed ID: 3336007
    [Abstract] [Full Text] [Related]

  • 10. Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding.
    Scherman D, Henry JP.
    Mol Pharmacol; 1984 Jan 28; 25(1):113-22. PubMed ID: 6708929
    [Abstract] [Full Text] [Related]

  • 11. Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems.
    Naudon L, Leroux-Nicollet I, Costentin J.
    Brain Res; 1992 Oct 09; 593(1):32-8. PubMed ID: 1360863
    [Abstract] [Full Text] [Related]

  • 12. Functional molecular mass of binding sites for [3H]dihydrotetrabenazine and [3H]reserpine and of dopamine beta-hydroxylase and cytochrome b561 from chromaffin granule membrane as determined by radiation inactivation.
    Gasnier B, Ellory JC, Henry JP.
    Eur J Biochem; 1987 May 15; 165(1):73-8. PubMed ID: 3569299
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine.
    Scherman D, Jaudon P, Henry JP.
    Proc Natl Acad Sci U S A; 1983 Jan 15; 80(2):584-8. PubMed ID: 6572908
    [Abstract] [Full Text] [Related]

  • 14. [3H]Dihydrotetrabenazine binding to bovine striatal synaptic vesicles.
    Near JA.
    Mol Pharmacol; 1986 Sep 15; 30(3):252-7. PubMed ID: 3748008
    [Abstract] [Full Text] [Related]

  • 15. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
    Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O.
    J Neurosci; 2014 Jun 11; 34(24):8210-8. PubMed ID: 24920625
    [Abstract] [Full Text] [Related]

  • 16. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 17. Striatal dopamine deficiency in Parkinson's disease: role of aging.
    Scherman D, Desnos C, Darchen F, Pollak P, Javoy-Agid F, Agid Y.
    Ann Neurol; 1989 Oct 15; 26(4):551-7. PubMed ID: 2817829
    [Abstract] [Full Text] [Related]

  • 18. Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites.
    Naudon L, Raisman-Vozari R, Edwards RH, Leroux-Nicollet I, Peter D, Liu Y, Costentin J.
    Eur J Neurosci; 1996 Apr 15; 8(4):842-6. PubMed ID: 9081637
    [Abstract] [Full Text] [Related]

  • 19. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
    Cesura AM, Bertocci B, Da Prada M.
    Eur J Pharmacol; 1990 Sep 04; 186(1):95-104. PubMed ID: 2149340
    [Abstract] [Full Text] [Related]

  • 20. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F, Faucheux BA, Marquez J, Villares J, Menard JF, Agid Y, Hirsch EC.
    Brain Res; 1995 Sep 18; 692(1-2):233-43. PubMed ID: 8548309
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.